GluR2-Dependent Properties of AMPA Receptors Determine the Selective Vulnerability of Motor Neurons to Excitotoxicity

Philip Van Damme, Ludo Van Den Bosch, E Van Houtte, +2

Journal of Neurophysiology

Protective Effect of Parvalbumin on Excitotoxic Motor Neuron Death

Ludo Van Den Bosch, Beat Schwaller, V. Vleminckx, +9

Experimental Neurology

NeurophysiologyNeuroprotectionNeuroscienceBrain InjuryCentral Nervous System +4

Characterization of the Binding of Human Tissue-type Plasminogen Activator to Platelets

Douglas E. Vaughan, M E Mendelsohn, Paul Declerck, +3

Journal of Biological Chemistry

EngineeringCytoskeletonBiomedical EngineeringThrombin-stimulated PlateletsThrombosis +16

Calin from Hirudo medicinalis, an inhibitor of von Willebrand factor binding to collagen under static and flow conditions

Jolán Hársfalvi, JM Stassen, E Van Houtte, +3

Blood

Reactivated Recombinant Plasminogen Activator Inhibitor-1 (rPAI-1) Effectively Prevents Thrombolysis In Vivo

Douglas E. Vaughan, Paul Declerck, E Van Houtte, +2

Thrombosis and Haemostasis

ThrombopoiesisThrombosisVenous ThrombosisCardiovascular DiseaseReactivated Human Rpai-1 +13

Calin from Hirudo medicinalis, an inhibitor of platelet adhesion to collagen, prevents platelet-rich thrombosis in hamsters

Hans Deckmyn, J M Stassen, Ingrid Vreys, +3

Blood

Disturbed platelet aggregation to collagen associated with an antibody against an 85- to 90-Kd platelet glycoprotein in a patient with prolonged bleeding time

Hans Deckmyn, E Van Houtte, J. Vermylen

Blood

An α-mercaptoacrylic acid derivative (PD150606) inhibits selective motor neuron death via inhibition of kainate-induced Ca2+ influx and not via calpain inhibition

Ludo Van Den Bosch, Philip Van Damme, V. Vleminckx, +5

Neuropharmacology

Synaptic TransmissionCell DeathNeurotransmissionSynaptic SignalingSocial Sciences +15

Streptokinase-induced platelet aggregation. Prevalence and mechanism.

Douglas E. Vaughan, E Van Houtte, Paul Declerck, +1

Circulation

Studies of recombinant plasminogen activator inhibitor-1 in rabbits. Pharmacokinetics and evidence for reactivation of latent plasminogen activator inhibitor-1 in vivo.

Douglas E. Vaughan, Paul Declerck, E Van Houtte, +2

Circulation Research

MedicineImmunologyTherapeutic EfficacyPharmacokinetic ParametersClinical Pharmacology +9